
0:00
18:34
BridgeBio recently stopped their research and development of gene therapy for Galactosemia. This came as a shock to many of us. I talked to the CEO of BridgeBio on the phone, and in this episode I report back what he told me.
Więcej odcinków z kanału "The Galactosemia Podcast"



Nie przegap odcinka z kanału “The Galactosemia Podcast”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








